Maze; Mervyn
Patent Applications and Registrations
Patent applications and USPTO patent grants for Maze; Mervyn.The latest application filed is for "methods for reducing post-operative cognitive dysfunction (pocd)".
- Maze; Mervyn - San Francisco CA
- Maze; Mervyn - London GB
- Maze; Mervyn - London SW10 9NH GB
- Maze; Mervyn - Portola Valley CA
| Patent | Date |
|---|---|
| Methods For Reducing Post-operative Cognitive Dysfunction (pocd) App 20220112281 - Maze; Mervyn ; et al. | 2022-04-14 |
| Methods for reducing post-operative cognitive dysfunction (POCD) Grant 11,220,540 - Maze , et al. January 11, 2 | 2022-01-11 |
| Modulators of the eIF2alpha pathway Grant 11,220,477 - Walter , et al. January 11, 2 | 2022-01-11 |
| Method For Preventing Or Reducing Post-operative Cognitive Dysfunction (pocd) App 20200123245 - Maze; Mervyn ; et al. | 2020-04-23 |
| Modulators Of The Eif2alpha Pathway App 20190375704 - Walter; Peter ; et al. | 2019-12-12 |
| Modulators of the eIF2alpha pathway Grant 10,343,981 - Walter , et al. July 9, 2 | 2019-07-09 |
| Modulators Of The Eif2alpha Pathway App 20170342020 - Walter; Peter ; et al. | 2017-11-30 |
| Modulators of the eIF2alpha pathway Grant 9,708,247 - Walter , et al. July 18, 2 | 2017-07-18 |
| Methods App 20160333088 - Maze; Mervyn ; et al. | 2016-11-17 |
| Use of xenon as neuroprotectant in a neonatal subject Grant 9,326,996 - Franks , et al. May 3, 2 | 2016-05-03 |
| Method for treatment of post operative cognitive dysfunction Grant 9,308,254 - Maze , et al. April 12, 2 | 2016-04-12 |
| Modulators Of The Eif2alpha Pathway App 20160096800 - Walter; Peter ; et al. | 2016-04-07 |
| Use Of Xenon As Neuroprotectant In A Neonatal Subject App 20150216897 - Franks; Nicholas Peter ; et al. | 2015-08-06 |
| Methods App 20130084299 - Maze; Mervyn ; et al. | 2013-04-04 |
| Use of Hyperbaric Conditions to Provide Neuroprotection App 20100316729 - Franks; Nicholas Peter ; et al. | 2010-12-16 |
| Use Of Xenon As Neuroprotectant In A Neonatal Subject App 20090311340 - Franks; Nicholas Peter ; et al. | 2009-12-17 |
| Analgesic agent for newborn or fetal subjects Grant 7,632,872 - Franks , et al. December 15, 2 | 2009-12-15 |
| Use Of Xenon For Organ Protection App 20090252814 - Maze; Mervyn ; et al. | 2009-10-08 |
| Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass Grant 7,442,383 - Franks , et al. October 28, 2 | 2008-10-28 |
| Use of xenon with hypothermia for treating neonatal asphyxia Grant 7,390,508 - Franks , et al. June 24, 2 | 2008-06-24 |
| Use of xenon with hypothermia for treating neonatal asphyxia App 20070104796 - Franks; Nicholas Peter ; et al. | 2007-05-10 |
| Analgesic agent for newborn or fetal subjects App 20060233885 - Franks; Nicholas Peter ; et al. | 2006-10-19 |
| Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass App 20050238726 - Franks, Nicholas Peter ; et al. | 2005-10-27 |
| Neisseria mutants, lipooligosaccharides and immunogenic compositions App 20050106184 - Franks, Nicholas Peter ; et al. | 2005-05-19 |
| NMDA antagonist comprising xenon Grant 6,653,354 - Franks , et al. November 25, 2 | 2003-11-25 |
| Eliciting analgesia by transcranial electrical stimulation Grant 6,567,702 - Nekhendzy , et al. May 20, 2 | 2003-05-20 |
| Anaesthetic formulation comprising an NMDA-antagoinst and an alpha-2 adrenergic agonist Grant 6,562,855 - Franks , et al. May 13, 2 | 2003-05-13 |
| NMDA antagonist App 20020068764 - Franks, Nicholas Peter ; et al. | 2002-06-06 |
| NMDA antagonist Grant 6,274,633 - Franks , et al. August 14, 2 | 2001-08-14 |
| 4-substituted imidazole derivatives useful in perioperative care Grant 5,344,840 - Maze , et al. September 6, 1 | 1994-09-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 